Skip to main content
OpenTrials
Completed

NCT Number: NCT06404008

A Controlled Breathing Intervention to Reduce Stress and Improve Symptoms in COPD Patients (REST)

This is a parallel design, randomized, controlled pilot trial comparing a controlled breath intervention (REST) to usual care for reducing stress in individuals with COPD.

Completed

Looking for future studies?

Notify Me

Key information

Age range

40 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Ascension Seton Medical Center

Austin, Texas, 78705, United States

About this study

This is a parallel design, randomized, controlled pilot trial comparing a controlled breath intervention (REST) to usual care for reducing stress in individuals with chronic obstructive pulmonary disease (COPD). The intervention is based on the breathing techniques of Pranayama. It was developed with patient and stakeholder input and is targeted for individuals with COPD who have moderate levels of stress and symptom burden. The intervention is a 15-minute breathing protocol which will be taught to participants and subsequently evaluated in a clinic setting with surveys, lung function, and cardiac assessments. This intervention will be pre-tested in 6 individuals, revised, and piloted in 30 individuals (15 in intervention group, 15 in control group). This study will answer the question of 1) whether a controlled breath protocol is feasible, acceptable, and safe for patients with COPD and 2) whether any modifications to the intervention are needed for a future multicenter trial to be proposed and conducted after the completion of the pilot trial. We will also 3) obtain sufficient estimates of variability in stress measures to inform statistical planning of a future trial.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosis of spirometry confirmed COPD (FEV1/FVC <0.70 + FEV1<80%)
  • Perceived Stress Scale > 13
  • Age >40 years old
  • Able to read, write, and speak in English
  • Able to attend 1 in person training session and 1 in person trial sessions

Exclusion criteria

  • Current regular practice of breathing exercises or pranayama
  • No access to internet or telephone
  • Recent hospitalization for COPD exacerbation or any reason in the past 30 days
  • Other primary lung disease (ILD, asthma, bronchiectasis) by self-report or chart review
  • Non-correctable hearing impairment (i.e. hearing impairment despite hearing aids)
  • Severe cognitive impairment

Treatment and study plan

Rest

Behavioral

After randomization, individuals will attend an in-person training session in the REST protocol. This is a 15 minute controlled breath protocol that includes 3 yoga breathing techniques: 3-part dirgha breath, alternate nostril breathing, and 2:1 breathing. Each technique will be completed for 5 minutes, for a total of 15 minutes. After the training session, participants will practice the REST protocol for 15 minutes twice a day with guidance from research staff over zoom (Days 1-7) with daily COPD education including inhaler technique, nutrition, vaccinations, tobacco cessation counseling, and exacerbation education. On Day 8, participants will attend the Trial Session where they will complete the REST protocol (15 minutes) while vitals, lung function, and ECG measurements are taken. Surveys will be administered before and after the REST protocol to document patient reported stress and dyspnea.

Education

Other

After randomization, individuals will attend an in-person education session led by a research coordinator. For the following 7 days, the research staff will call patients daily and provide daily COPD education including inhaler technique, nutrition, vaccinations, tobacco cessation counseling, and COPD exacerbation education. On Day 8, participants will attend the Trial Session where they will do spontaneous breathing (15 minutes) while vitals, lung function, and EKG measurements are taken. Surveys will be administered before and after the spontaneous breathing period to document patient reported stress and dyspnea. After the study, participants will be asked to complete a close out survey and interview over zoom.

Primary outcomes

  1. Intervention Feasibility

    Time frame: 6 months

    IG: Completion of 2 in-person sessions (1 training, 1 trial) along with >80% of daily individual practice of breathing protocol (15 minute twice daily)

  2. Trial feasibility

    Time frame: 6 months

    Rates of screening, enrollment, retention, reasons for exclusion and refusals, and attrition. Attrition goal <10% throughout study period.

  3. Acceptability (quantitative)

    Time frame: 6 months

    Post-intervention survey on intervention acceptability with Likert scale rated 1 to 10; 10 being most acceptable. Overall average score ≥8 of 10 defined as acceptable. Will assess patient reported enjoyment, difficulty, and adherence

  4. Acceptability (qualitative)

    Time frame: 6 months

    Post-intervention semi-structured, in-depth interviews by telephone conducted by study coordinator to explore acceptability, barriers, facilitators, and survey burden

Secondary outcomes

  1. Perceived Stress Scale

    Time frame: Day 0, Day 8

    10-item questionnaire with a score of 0-40, with higher scores indicating higher levels of stress.

  2. Modified Medical Research Council dyspnea scale

    Time frame: Day 0, Day 8

    Self-rating tool to measure the degree of disability that breathlessness poses on day-to-day activities on a scale from 0 to 4

  3. Mindful Attention Awareness Scale

    Time frame: Day 0, Day 8

    The MAAS is a 15-item scale designed to assess a core characteristic of dispositional mindfulness, namely, open or receptive awareness of and attention to what is taking place in the present

Other outcomes

  1. Lung Function

    Time frame: Day 0, Day 8

    Forced expiratory volume in 1 second (L), Forced vital capacity, Inspiratory capacity

  2. Heart rate variability

    Time frame: Day 0, Day 8

    Derived from 10-second ECG

Sponsors and collaborators

Lead sponsor

University of Texas at Austin

Other

Registry information

Official study title

A Controlled Breathing Intervention to Reduce Stress and Improve Symptoms in COPD Patients (REST): A Randomized Pilot Trial

Acronym: REST

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
May 8, 2024
Registry last updated
Nov 17, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.